Fig. 3From: Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implicationsPD-L1 mRNA expression in tumors with JAK2 gain (amplification) or loss (nonsense mutations or homozygous deletion) in the TCGA cohort. Gene expression data are log2-transformed RSEM values derived from RNA-seq (see “Methods”)Back to article page